(Q34298801)

1 August 2017

title

Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole (English)

1 reference

1 August 2017

1 reference

Rhoden EL

1

1 reference

1 August 2017

Morgentaler A

series ordinal

2

1 reference

1 August 2017

publication date

1 February 2004

1 reference

International Journal of Impotence Research

1 August 2017

published in

1 reference

1 August 2017

volume

16

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

95-97

1 reference

Clinical review 134: The endocrinology of prostate cancer

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901154

AROMATASE INHIBITORS FOR MALE INFERTILITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901154

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901154

The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901154

Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901154

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.IJIR.3901154

1 reference

Dimensions Publication ID

1 August 2017

1053107817

0 references

1 reference